Profound Medical Corp
TSX:PRN

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
TSX:PRN
Watchlist
Price: 8.68 CAD -1.92% Market Closed
Market Cap: 260.7m CAD

Profound Medical Corp
Investor Relations

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Show more
Loading
PRN
S&P TSX Composite Index (Canada)

Earnings Calls

2024 Q4
Feb 13, 2025
Show Transcript
Previous
Next
Wilhelmsen Group Reports Strong Performance with Dividend Growth
2024 Q4
Feb 13, 2025

The Wilhelmsen Group reported robust performance driven by its subsidiary Wallenius Wilhelmsen, yielding an $171 million dividend for the quarter and a total of $282 million for the year. This resulted in an 18% return for shareholders. The company announced financial health with a 72% equity ratio and ongoing contract renegotiations enhancing business strength. Earnings before interest, taxes, depreciation, and amortization (EBITDA) experienced an 11% year-over-year rise, reaching $16 million. Management forecasts a first dividend of NOK 12 per share with a potential total of NOK 20, underscoring continued commitment to shareholder value amidst strategic growth initiatives.

Show Full Analysis

Management

Dr. Arun Swarup Menawat MBA, Ph.D.
Chairman of the Board & CEO
No Bio Available
Dr. Mathieu Burtnyk Ph.D.
President
No Bio Available
Mr. Rashed Dewan
Chief Financial Officer
No Bio Available
Mr. Stephen Kilmer
Investor Relations
No Bio Available
Mr. Thomas Tamberrino MBA
Chief Commercial Officer
No Bio Available
Mr. Matthew Sobczyk C.A., CPA
Assistant Corporate Controller
No Bio Available
Mr. Levant Tinaz
Software Developer
No Bio Available

Contacts

Address
ONTARIO
Mississauga
2400 Skymark Ave Unit 6
Contacts